story of the week
Chemotherapy + Cetuximab Improves Survival in EGFR-Expressing NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology